Oncologic Therapies

2. Auflage 2003. Softcover Nachdruck of the original 2. Auflage 2003
ISBN: 978-3-642-62818-4
Verlag: Springer

Buch, Englisch, 659 Seiten, Paperback, Format (B × H): 193 mm x 242 mm, Gewicht: 1291 g

Each individual chapter of this shortened new edition is structured in the same way and features a brief outline or tabular summary of the main aspects of epidemiology, pathology, staging and diagnosis. The main focus is on the therapeutic strategy, i.e., an interdisciplinary approach to systemic drug therapy. Surgical and radiological concepts of treatment are also covered, as are supportive care, pain relief methods and ethical problems. A must for clinicians and practitioners as well as interns, residents and postgraduate students.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Golomb, Harvey M.

Vokes, Everett E.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Radiologie, Bildgebende Verfahren
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Hämatologie, Transfusionsmedizin

Inhaltsverzeichnis

1 Principles of Surgical Oncology.- 2 Principles of Radiation Oncology*euticModalities.- 3 Principles of Cancer Chemotherapy.- 4 Principles of Cancer Chemoprevention.- 5 Principles of Cancer Immunotherapy.- 6 Ethics and the Development of New Oncologic Therapies:*Informed Consent, Equipoise, and the Randomized Trial.- 7 Diagnosis and Management of Oncologic Emergencies.- 8 Infectious Complications of Oncologic Therapy.- 9 Hematopoietic Growth Factors.- 10 Pain Management.- 11 Chemotherapy-Induced Nausea and Vomiting.- 12 Pleural Effusions.- 13 Measuring Quality of Life.- 14 Acute Leukemia.- 15 Chronic Myelogenous Leukemia.- 16 Chronic Lymphocytic Leukemia.- 17 Myelodysplastic Syndromes.- 18 Myeloproliferative Disorders.- 19 Hairy Cell Leukemia.- 20 Hodgkin’s Lymphoma.- 21 Cutaneous T Cell Lymphomas.- 22 Non-Hodgkin’s Lymphoma.- 23 Multiple Myeloma and Other Plasma Cell Dyscrasias.- 24 Early Breast Cancer.- 25 Locally Advanced, Locally Recurrent,*and Metastatic Breast Cancer.- 26 Head and Neck Tumors.- 27 Carcinoma ofthe Esophagus.- 28 Non-Small Cell Lung Cancer.- 29 Small Cell Lung Cancer.- 30 Mesothelioma.- 31 Colorectal Cancer.- 32 Anal Cancers.- 33 Gastric Cancer.- 34 Hepatobiliary Cancer, Pancreatic Cancer,*and Neuroendocrine Cancers of the Gastrointestinal Tract.- 35 Prostate Cancer.- 36 Testicular Cancer.- 37 Renal Cancer.- 38 Genitourinary Malignancies: Bladder/Penis/Urethral Cancers.- 39 Uterine Cancer.- 40 Cervical, Vulvar, and Vaginal Cancer.- 41 Ovarian Cancer.- 42 Primary and Metastatic Brain Tumors.- 43 Bone Sarcomas.- 44 Soft-Tissue Sarcomas.- 45 Thyroid Malignancies.- 46 Cutaneous Melanoma.- 47 Non-Melanoma Skin Neoplasms.